Rosemont Pharmaceuticals Overview
- Year Founded
-
1967
- Status
-
Private
- Employees
-
250
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
4
- Investments
-
4
Rosemont Pharmaceuticals General Information
Description
Manufacturer of oral liquid formulations of off-patent and solid-dose pharmaceutical products intended for patients with swallowing difficulties. The company offers liquid and solid medications and also provides medicines for anesthesia, the cardiovascular system, the central nervous system, the endocrine system, the gastrointestinal system, infections, malignant disease and immunosuppression, and other diseases, thereby enabling patients to improve their health.
Contact Information
Website
www.rosemontpharma.comCorporate Office
- Rosemont House
- Yorkdale Industrial Park, Braithwaite Street
- Leeds LS11 9XE
- England, United Kingdom
Corporate Office
- Rosemont House
- Yorkdale Industrial Park, Braithwaite Street
- Leeds LS11 9XE
- England, United Kingdom
Rosemont Pharmaceuticals Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Rosemont Pharmaceuticals Comparisons
Industry
Financing
Details
Rosemont Pharmaceuticals Competitors (1)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Laxmi Bns Holdings | Corporation | Ruislip, United Kingdom |
Rosemont Pharmaceuticals Patents
Rosemont Pharmaceuticals Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
GB-202407814-D0 | Phenobarbital oral composition and method of manufacture/use thereof | Pending | 03-Jun-2024 | ||
EP-4122450-A1 | Liquid pharmaceutical composition of clonidine | Pending | 20-Jul-2021 | ||
CA-3168005-A1 | Liquid pharmaceutical composition of clonidine | Pending | 20-Jul-2021 | ||
GB-202110420-D0 | Liquid pharmaceutical composition of clonidine | Inactive | 20-Jul-2021 | ||
US-20220016074-A1 | Oral topiramate suspension formulations with extended shelf stability and enhanced bioavailability | Pending | 21-Nov-2018 | A61K9/10 |
Rosemont Pharmaceuticals Signals
Rosemont Pharmaceuticals Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
Rosemont Pharmaceuticals Investments (4)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Sabal Therapeutics | 08-Jul-2024 | Other Healthcare Services | |||
Pharma-Data | 20-Jun-2024 | Drug Discovery | |||
Lucis Pharma | 16-Jun-2023 | Consulting Services (B2B) | |||
Essential Pharma (UK Oral Liquid Portfolio) | 25-Nov-2021 | Buyout/LBO | Buildings and Property |
Rosemont Pharmaceuticals Subsidiaries (3)
Company Name | Industry | Location | Founded |
---|---|---|---|
Sabal Therapeutics | Other Healthcare Services | Watkinsville, GA | 2016 |
Lucis Pharma | Consulting Services (B2B) | Leeds, United Kingdom | |
Pharma-Data | Drug Discovery | Lavrion, Greece |
Rosemont Pharmaceuticals FAQs
-
When was Rosemont Pharmaceuticals founded?
Rosemont Pharmaceuticals was founded in 1967.
-
Where is Rosemont Pharmaceuticals headquartered?
Rosemont Pharmaceuticals is headquartered in Leeds, United Kingdom.
-
What is the size of Rosemont Pharmaceuticals?
Rosemont Pharmaceuticals has 250 total employees.
-
What industry is Rosemont Pharmaceuticals in?
Rosemont Pharmaceuticals’s primary industry is Pharmaceuticals.
-
Is Rosemont Pharmaceuticals a private or public company?
Rosemont Pharmaceuticals is a Private company.
-
What is the current valuation of Rosemont Pharmaceuticals?
The current valuation of Rosemont Pharmaceuticals is
. -
What is Rosemont Pharmaceuticals’s current revenue?
The current revenue for Rosemont Pharmaceuticals is
. -
How much funding has Rosemont Pharmaceuticals raised over time?
Rosemont Pharmaceuticals has raised $76.5M.
-
Who are Rosemont Pharmaceuticals’s investors?
Inflexion Private Equity Partners has invested in Rosemont Pharmaceuticals.
-
Who are Rosemont Pharmaceuticals’s competitors?
Laxmi Bns Holdings is a competitor of Rosemont Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »